Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 31, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

Allergopharma and S-TARget Conclude Licensing Agreement
Wednesday, September 10, 2014
Objective is new generation of therapeutics for allergy treatment.

Abcam Announces Appointment of New CEO and Board Changes
Tuesday, September 09, 2014
The previous long-serving Chief Executive and co-Founder of Abcam, Jonathan Milner, will continue to play an active role in the Company as Deputy Chairman.

Rockland Awarded SBIR Funding
Tuesday, September 09, 2014
Company awarded grant to develop antibody-based point of care device for the diagnosis of sickle cell disease.

Novel Immunotherapy Breast Cancer Vaccine
Tuesday, September 09, 2014
Vaccine Decreases Recurrence in HER2 Positive Breast Cancer Patients.

Cell ‘Memory’ Could be Key to Strengthen Vaccine Efficacy
Tuesday, September 09, 2014
Virginia Tech Carilion Research Institute scientists uncover immune system secret.

Apitope Treatment Approach Published in Nature Communications
Monday, September 08, 2014
Scientists discover how to 'switch off' autoimmune diseases.

Abcam and Cell Marque Sign Global Strategic Marketing Agreement
Saturday, September 06, 2014
Partnership extends Abcam’s reach within in vitro diagnostics market.

NIH-Led Scientists Discover HIV Antibody that Binds to Novel Target on Virus
Friday, September 05, 2014
The antibody, 35O22, prevents 62 percent of known HIV strains from infecting cells in the laboratory.

Breakthrough Melanoma Treatment, Keytruda, Developed
Friday, September 05, 2014
New immunotherapy launched in the US for treatment of adults with advanced melanoma, developed using antibody humanization expertise at UK’s MRC Technology.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 1225
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv